C
fibroblast growth factor 23
Novel & Emerging BiomarkersLab test / biomarkerrisknon modifiable
13
evidence score
Also known as: fgf-23, fgf23
PREVENT status
Not a PREVENT input variable.
Causal support
observational only
Score components
lit volume: 7.8meta-analyses: 0trials: 4.8genetic: 0MR bonus:
References (5)
0 meta-analyses / systematic reviews- The bone-heart axis: A crucial dialogue in cardiovascular disease. — Metabolism: clinical and experimental 2025 · PMID 40543811
- Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study. — Clinical journal of the American Society of Nephrology : CJASN 2023 · PMID 36719157
- FGF23 and klotho at the intersection of kidney and cardiovascular disease. — Nature reviews. Cardiology 2023 · PMID 37443358
- An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk — Frontiers in Physiology 2021 · PMID 33767635
- Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease — JAMA Cardiology 2017 · PMID 28329057
Clinical trials (2)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT04327492 | Clinical, Hematological, and Imagiologic Predictors of Postoperative Complications and Long Term Cardiovascular Events After Carotid Endarterectomy With Regional Anesthesia | UNKNOWN | OBSERVATIONAL | Biomarker - FGF 23; troponin I; PCR - high sensitivity; BNP |
| NCT05214872 | Assessment of the Impact of Selected Factors on the Cardiovascular System in Patients With Different Chronic Kidney Disease Stages | COMPLETED | OBSERVATIONAL | laboratory parameters - complete blood count, body mass index (BMI) [kg/m^2] calculation, selected parameters of oxidative stress (1) |
Genetic associations (0)
None linked.